BeOne Medicines AG Overview
Get informed when a big investor buys or sells
+ Follow18.39
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
BeOne Medicines AG (ONC) currently reports a PEG ratio of 18.39. That is below the Healthcare sector average of 27.75. Use the charts on this page to explore BeOne Medicines AG's PEG ratio history and peer comparisons.
BeOne Medicines AG's PEG ratio of 18.39 is lower than the Healthcare sector average of 27.75. That is roughly 33.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates BeOne Medicines AG's market price to a fundamental measure such as earnings, sales, or book value. At 18.39, ONC can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of 18.39, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 27.75. From there, open related valuation or income-statement pages for BeOne Medicines AG, and consider following ONC for alerts when major investors trade the stock.
BeOne Medicines AG is classified in the Healthcare sector. On PEG ratio, it currently shows 18.39 versus a sector average near 27.75. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ONC with unrelated industries.
